Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis

NCT04562389 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

353

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelofibrosis

Interventions

DRUG: Selinexor
DRUG: Selinexor
OTHER: Placebo
DRUG: Ruxolitinib

Sponsor

Karyopharm Therapeutics Inc